How to Invest in OpenAI: The Honest Routes

How to invest in OpenAI is the question behind the gated half of Dr. Mark Skousen and Matt McCall’s “XAI Boom” presentation: the pitch’s “second IPO” pick, hidden behind McCall’s report, is a public company that “poured more than $60,000,000,000 into the maker of ChatGPT.” If you searched the question, here are the honest routes, what the pitch actually claims, and what verifies, with the standing precision that the campaign never names its OpenAI backdoor, so the identification is our high-confidence read. The complete treatment is our XAI Boom review. For the full backstory, see our How to Invest in OpenAI in 2026: The Routes article.

The Pitch’s OpenAI Fingerprint

The presentation describes its gated pick: “On the surface, it sounds like another boring bank. But over the past couple years, it’s poured more than $60,000,000,000 into the maker of ChatGPT… This company also controls one of the most important chipmakers on earth… NVIDIA even tried to buy this company outright at one point.”

That profile points toward SoftBank: the tens of billions committed to OpenAI across the Stargate partnership and related vehicles, the control of Arm (one of the most important chip designers on earth), and Nvidia’s documented approach history all match. But the promo never names it, so the identification stays with the reader’s own verification: check the OpenAI investment commitments, the Arm ownership, and the Nvidia approach reporting, and the fingerprint resolves or it does not. The mechanism the pitch teaches is McCall’s “second IPO” concept: “When the private company goes public, the market suddenly wakes up to the value that’s hiding inside the company that already owns it.”

The Real Routes, Ranked

Route one, the backdoor stake-holder: buying a public company that holds a large OpenAI position. The precedents the pitch cites are real: Ford’s 12% Rivian stake preceded Ford stock popping at the IPO, and Yahoo’s 40% Alibaba stake preceded a triple in the two years around that IPO. The honest caveats: both precedents also prove the ceiling of the mechanism, since the stake is one asset inside a larger business, and the paper value’s flow-through to the share price is partial and unpredictable.

Route two, pre-IPO funds and interval vehicles: genuine exposure with fees, lockups, and opaque marks; the least liquid, most direct route. The pitch does not address it.

Route three, waiting for the listing: the simplest route, with the twin costs of missing the pre-IPO re-rating and paying the listing-day price. The pitch’s framing of an OpenAI IPO timeline is worth flagging on its own: the transcript is internally inconsistent, with one line saying OpenAI “went public at nearly $2,000,000,000,000” and other passages treating the IPO as upcoming, a caption-drafting artifact near the event that our review flagged as the campaign’s sloppiest inconsistency. A reader should check the actual listing status before acting on any timeline claim in this pitch.

The Honest Read

What the pitch gets right: the second-IPO mechanism is a genuinely interesting lens on pre-IPO access, the precedents are real and checkable, and the fingerprint is specific enough to resolve. The free companion pick, SK Telecom as the Anthropic backdoor (documented stake, NYSE listing), demonstrates the same mechanism with better sourcing, and our SK Telecom profile covers it; the comparison piece on the two routes is our Anthropic vs OpenAI breakdown.

The caveats. Both routes are venture-stake bets with the same vulnerability: if the assumed IPO valuations compress, the scenario ladders collapse, and the pitch’s dollar-outcome language (“nine times your money”) is extrapolation on estimates. McCall’s own disclaimer is the right lens: “I can’t promise you any specific outcome.” And the portfolio-construction point matters most here: a reader holding both backdoors plus the publisher’s sibling Anthropic campaign is tripling up on the same frontier-AI exposure, which is concentration wearing a diversification costume.

Frequently Asked Questions

Can I buy OpenAI shares directly? Not through the pitch’s route map. The campaign’s answer to pre-IPO access is the backdoor: buy the public owner of a stake, per the mechanism “When the private company goes public, the market suddenly wakes up to the value that’s hiding inside the company that already owns it.” Direct pre-IPO exposure exists only through venture or interval vehicles with fees, lockups, and opaque marks, a route the pitch does not address.

How do I verify the gated pick? Work the fingerprint: “poured more than $60,000,000,000 into the maker of ChatGPT,” “controls one of the most important chipmakers on earth,” and “NVIDIA even tried to buy this company outright at one point.” Each clause is checkable against public reporting on OpenAI’s funding commitments, Arm’s ownership, and Nvidia’s approach history. If all three resolve to one company, you have your answer; the promo will not give it to you.

What if the listing already happened? Check first. The transcript is internally inconsistent (one caption says OpenAI “went public at nearly $2,000,000,000,000,” other passages treat the IPO as upcoming), so the pre-IPO window’s status is a fact to verify, not a premise to accept.

What does this mean? The honest route map is a risk-shape map. The backdoor is liquid but diluted; the pre-IPO vehicle is direct but locked; the listing is simple but you pay the re-rating to someone else. McCall’s disclaimer prices all three: “I can’t promise you any specific outcome.”

The Offer

The bundle carrying the OpenAI blueprint: a year each of The Skousen Report and McCall’s Innovation Report, “The Second IPO Blueprint” with the OpenAI stake company’s identity and thesis, “Machine Medicine,” the Private Power Boom report, the final exit plan, and The Maxims of Wall Street, at “$795… for just $129” with 90 days, full refund, reports kept. The full presentation is here.

NewsletterVetter is an independent publication. We receive compensation from some of the services we review through affiliate links. Nothing on this site is investment advice. Always do your own research.